Ignite Creation Date:
2024-05-06 @ 2:51 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02140463
Status:
COMPLETED
Last Update Posted:
2022-06-15
First Post:
2014-02-10
Brief Title:
Next Generation pErsonalized tXTherapy With Plasma DNA Trial-2 in Refractory Solid Tumors The NEXT-2 Trial
Sponsor:
Organization:
Samsung Medical Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
circulating free DNA
Enrollment Count:
229
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 25704 |
Who Masked List: